Firm & Final

BCS Financial

High Drug Costs: Innovation, Access, & Affordability | Pat Gleason, Ramesh Jayasuriya, Jim Clement

JUL 16, 202633 MIN

Description

Pharmaceutical costs are one of the key factors driving increased health care expenditures in the U.S. Which is pretty stunning when you consider that most Americans don’t have any idea how those drugs are priced, or even how they get to market.  So in this episode, we’re exploring the complexities of high-cost drugs, including gene therapies and specialty medications, with some of the top experts from the Blue Cross Blue Shield family of companies. Joining us are Pat Gleason from Prime Therapeutics, Ramesh Jayasuriya from Evio, and Jim Clement from Synergie. Together, we’ll have a very frank conversation where we try to define what constitutes a specialty medication, explain how value-based contracting and warranties work, and explore what the future may hold for pricing in the pharmaceutical industry.  And, each panelist will offer up what they see as some potential solutions to help improve drug affordability and access in the U.S. healthcare system. 🖥️ Play on BCS website – https://bcsf.com/firmandfinalpodcast/  🎧 Listen on Spotify – https://spoti.fi/3U7rYuq  🍎 Listen on Apple Podcasts – https://apple.co/3Kvdlhg  ☑️ Sign up to subscribe – https://bcsf.com/firmandfinalpodcast/  🦸 Recommend a Legend – [email protected]